Ifp Advisors, Inc Provention Bio, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$5.59 - $7.39 $234 - $310	-42 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$5.66 - $8.33 $237 - $349	42 New	42 $1,000
Q2 2021 Jul 13, 2021	BUY	$6.71 - $11.04 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$10.12 - $19.45 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$11.79 - $18.94 $11,790 - $18,940	-1,000 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$10.34 - $15.2 $10,340 - $15,200	1,000 New	1,000 $13,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.